Ack3 Bionetics Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Active
Last Updated:
About Ack3 Bionetics Private Limited

Ack3 Bionetics Private Limited, a active private limited company, was established on 19 January 2017 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2017PTC289776. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Raju Adsul Sunil (Additional Director), Shrish Ajitbhai Ruparel (Additional Director). Past directors included Manoj Mahadeo Phadke, Jiten Chhaganlal Chandra, Ravindra Bhaskar Deshmukh. It is based at Unit No. 422, 4Th Floor, Laxmi Plaza Laxmi Industrial Estate, New Link Road,, Andheri(W), Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2017PTC289776

  • Registration Number

    289776

  • Incorporation Date

    19 January 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 1 Month
Company report

Ack3 Bionetics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ack3 Bionetics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ack3 Bionetics Private Limited?
Current Directors
Name Designation Appointment Date Status
Raju Adsul Sunil Additional Director 24 May 2019 Current
Shrish Ajitbhai Ruparel Additional Director 04 Dec 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Dec 2017 Past
Pramod Abcsdd Additional Director 04 Jun 2019 Past
Pramod Abcsdd Director 04 Dec 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ack3 Bionetics.

Enhance accessibility to Ack3 Bionetics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ack3 Bionetics revenue growth over time
Ack3 Bionetics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ack3 Bionetics?

Unlock access to Ack3 Bionetics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ack3 Bionetics?

Unlock and access historical data on people associated with Ack3 Bionetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ack3 Bionetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ack3 Bionetics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ack3 Bionetics
Recent Activity within the Organization
  • Director Appointment

    Raju Adsul Sunil was appointed as a Additional Director was appointed as a Additional Director on 24 May 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Shrish Ajitbhai Ruparel was appointed as a Additional Director was appointed as a Additional Director on 04 Dec 2017 & has been associated with this company since 8 years 2 months . was documented.

  • Company Incorporation

    The activity Ack3 Bionetics Private Limited was registered on 19 Jan 2017 with Roc Mumbai I & aged 9 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ack3 Bionetics Private Limited?

The CIN of Ack3 Bionetics Private Limited is U74999MH2017PTC289776.

Where is Ack3 Bionetics Private Limited headquartered?

Ack3 Bionetics Private Limited is headquartered at Unit No. 422, 4Th Floor, Laxmi Plaza Laxmi Industrial Estate, New Link Road,, Andheri(W), Mumbai, Maharashtra, 400053.

When was Ack3 Bionetics Private Limited incorporated?

Ack3 Bionetics Private Limited was incorporated on 19 January 2017.

Who are the current directors of Ack3 Bionetics Private Limited?

The current directors of Ack3 Bionetics Private Limited are

What is the primary industry of Ack3 Bionetics Private Limited?

The primary industry of Ack3 Bionetics Private Limited is Business Services.

Is Ack3 Bionetics Private Limited a listed company?

Ack3 Bionetics Private Limited is unlisted.

What is the capital structure of Ack3 Bionetics Private Limited?

The authorized capital of Ack3 Bionetics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Ack3 Bionetics Private Limited?

The compliance status of Ack3 Bionetics Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available